July 5, 2016

Tony winner Kelli O’Hara to headline 21st annual
Symphony at Salk

Salk News


Tony winner Kelli O’Hara to headline 21st annual Symphony at Salk

LA JOLLA—The Salk Institute will celebrate 21 years of Symphony at Salk, its signature concert under the stars, with Broadway luminary Kelli O’Hara and the incomparable San Diego Symphony led by guest conductor Maestro Thomas Wilkins on Saturday, August 20.

O'Hara, Kelli - photo
Kelli O’Hara

The gala evening concert on the courtyard of the Louis Kahn-designed Institute will showcase O’Hara performing her Broadway showstoppers and selections from the Great American Songbook. Her portrayal of Anna Leonowens in the critically acclaimed revival of The King and I garnered her the 2015 Tony Award for Best Leading Actress in a Musical. Since her Broadway debut in Jekyll & Hyde in 2000, she has moved from one critical and commercial success to another, earning numerous Tony, Drama Desk, Drama League and Outer Critics Circle nominations. A recent New York Times review of her operatic turn in Dido and Aeneas raved, “Ms. O’Hara can sign a Rodgers and Hammerstein number as if she were talking to you, while still bringing exquisite sound to her phrases.”

Individual tickets for Symphony at Salk are $300 and include a champagne reception and gourmet dinner. All proceeds support the Institute’s wide-ranging scientific inquiries that have yielded more than 50 years of life-changing discoveries, directly influencing areas as diverse as cancer, Alzheimer’s Parkinson’s, metabolic diseases, ALS, schizophrenia, autism, spinal cord injuries, crop yields and world hunger. Proceeds also support Salk’s award-winning educational outreach programs that have helped generations of students discover their passion for research and explore careers in science.

Tickets can be purchased online at www.salk.edu/symphony. For more information, call (858) 597-0657.

For More Information

Office of Communications
Tel: (858) 453-4100
press@salk.edu

The Salk Institute For Biological Studies:

The Salk Institute is an independent, nonprofit research institute founded in 1960 by Jonas Salk, developer of the first safe and effective polio vaccine. The Institute’s mission is to drive foundational, collaborative, risk-taking research that addresses society’s most pressing challenges, including cancer, Alzheimer’s, and agricultural resilience. This foundational science underpins all translational efforts, generating insights that enable new medicines and innovations worldwide.